Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3/MKK 6 pathway in vascular smooth muscle cells

European Journal of Clinical Investigation

Volumn 30, Issue 8, 2000, Pages 668-677

  Igarashi, M ^a   Yamaguchi, H ^a   Hirata, A ^a   Daimon, M ^a   Tominaga, M ^a   Kato, T ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Insulin; MKK 3 6; p38 MAP kinase; p70 S6 kinase; Vascular smooth muscle cell

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DNA; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE C INHIBITOR; S6 KINASE; TRITIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HORMONAL REGULATION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; DNA; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; IMIDAZOLES; INDOLES; INSULIN; MALE; MALEIMIDES; MAP KINASE KINASE 3; MAP KINASE KINASE 6; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PYRIDINES; RATS; RATS, WISTAR; RIBOSOMAL PROTEIN S6 KINASES; TIME FACTORS;

EID: 0033864101     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00671.x     Document Type: Article

References (51)

1. 1 White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994;269:1-4.
2. 2 Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocrinol Rev 1995;16:117-42.
3. 3 Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726-98.
4. 4 Kundra V, Escobedo J, Kazlauskas A, Kim H, Rhee S, Williams L et al. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature 1994;367:474-6.
5. 5 Bilato C, Pauly R, Melillo G, Monticone R, Gorelick-Feldman D, Gluzband Y et al. Intracellular signaling pathways are required for rat vascular smooth muscle cell migration. J Clin Invest 1995;96:1905-15.
6. 6 Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265:808-11.
7. 7 Chen YR, Wang X, Templeton D, Davis RJ, Tan TH. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 1996;271:31929-36.
8. 8 Liu Y, Gorospe M, Yang C, Holbrook NJ. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J Biol Chem 1995;270:8377-80.
9. 9 Osborn MT, Chambers TC. Role of the stress-activated/ c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J Biol Chem 1996;271:30950-5.
10. 10 Heine H, Ulmer AJ, Flad HD, Hauschildt S. Lipopolycaccharide-induced change of phosphorylation of two cytosolic proteins in human monocytes is prevented by inhibitors of ADP-ribosylation. J Immunol 1995;155:4899-908.
11. 11 Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994;372:739-46.
12. 12 Nick JA, Avdi NJ, Gerwins P, Johnson GL, Worthen GS. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccaride. J Immunol 1996;156:4867-75.
13. 13 Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 1995;92:12230-4.
14. 14 Moriguchi T, Kawasaki H, Matsuda S, Gotoh Y, Nishida E. Evidence for multiple activators for stress-activated protein kinase/c-Jun amino-terminal kinases. J Biol Chem 1995;270:12969-72.
15. 2-kinase by UV irradiation is dependent on p21ras. J Biol Chem 1996;271:23304-9.
16. 16 Stein B, Brady H, Yang MX, Young DB, Barbosa MS. Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase cascade. J Biol Chem, 199;271:11427-33.
17. 17 Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D et al. A novel kinase cascade triggered by stress and heat shock that stimulate MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994;78:1027-37.
18. 18 Modur V, Zimmerman GA, Prescott SM, McIntyre TM. Endotherial cell inflammatory responses to tumor necrosis factor α. J Biol Chem 1996;271:13094-102.
19. 19 Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995;270:7420-6.
20. 20 Beyaert R, Cuenda A, Berghe WV, Plaisance S, Lee JC, Haegeman G et al. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor. EMBO J 1996;15:1914-23.
21. 21 Cuenda A, Cohen P, Buee-Scherrer V, Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 1997;16:295-305.
22. 22 Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-30.
23. 2) in thrombin-stimulated platelets. J Biol Chem 1996;271:27723 9.
24. 24 Stout RW. Insulin and atheroma. Diabetes Care 1990 13:631 54.
25. 25 Agewall S, Wikstrand J, Suurkula M, Tengborn L, Fagertberg B. Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease. Blood Coagul Fibrinolysis 1994;5:895-904.
26. 26 Bonner G. Hyperinsulinemia, insulin resistance, and hypertension. J Cardiovasc Pharmacol 1994;24 (Suppl. 2):S39-49.
27. 27 Giugliano D, Acampora R, D'Onofrio F. Medical hypothesis: cardiovascular complications of diabetes mellitus - from glucose to insulin and back. Diabetes Metab 1994;20:445-53.
28. 28 Stern MP. Diabetes and cardiovascular disease. The 'common soil' hypothesis. Diabetes 1995;44:369-74.
29. 29 Ross R. The pathogenesis of atherosclerosis - a perspective for the 1990s. Nature 1993;362:801-9.
30. 30 Li H, Freeman MW, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995;95:122-33.
31. 31 Igarashi M, Takeda Y, Ishibashi N, Takahashi K, Mori S, Tominaga T et al. Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization. Horm Metab Res 1997;29:444-9.
32. 32 Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 1999;103:185-95.
33. 33 Bradford MM. A rapid and sensitive method of the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
34. 34 Mori S, Kawano M, Kanzaki T, Morisaki N, Saito Y, Yoshida S. Decreased expression of the platelet-derived growth factor β-receptor in fibroblast from a patient with Werner's syndrome. Eur J Clin Invest 1993;23:161-5.
35. 35 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1950;193:265-75.
36. 36 Gerhardt CG, Gros J, Strosberg AD, Issard T. Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human β-3 adrenergic receptor: new pharmacological profile and mechanism of activation. Mol Pharmacol 1999;55:255-62.
37. 37 Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF et al. SB203580 is a specific inhibitor of MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995;364:229-33.
38. 38 Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-94.
39. 39 De Groot RP, Ballou LM, Sassone-Corsi P. Positive regulation of the cAMP-responsive activator CREM by the p70, S6 kinase: an alternative route to mitogen-induced gene expression. Cell 1994;79:81-91.
40. 40 Derijard B, Raingeaud J, Barrett T, Huan WI, Han J, Ulevitch RJ et al. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995;267:682-5.
41. 41 Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ. MKK3-and MKK-6 regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 1996;16:1247-55.
42. 42 Lin A, Minden A, Martinetto H, Claret FX, Lange-Carter C, Mercurio F et al. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 1995;268:286-90.
43. 43 Heidenreich KA, Krummer JL. Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 1996;271:9891-4.
44. 44 Tsakiridis T, Taha C, Grinstein S, Klip A. Insulin activates a p21-activated kinase in muscle cells via phosphatidylinositol 3-kinase. J Biol Chem 1996;271:19664-7.
45. 45 Wang X, Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 1996;272:1347-9.
46. 46 Ha J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997;386:296-9.
47. 47 Vanden-Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W et al. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 1998;273:3285-90.
48. 48 Taha C, Tsakiridis T, McCall A. Klip A Glucose transporter expression in L6 muscle cells: regulation through insulin-and stress-activated pathways Am J Physiol 1997;273:E68-76.
49. 49 Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 1999;274:10071-8.
50. 50 Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 1997;16:1909-20.
51. 12 in vivo mimics insulin activation of c-Jun N-terminal kinase and p38 kinase. J Biol Chem 1998;273:16487-93.